| Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer (NCT04108481) | University of Iowa | 2020-10-05 |
| Imaging Neural Correlates of Ketamine Using PET/MR (NCT04587778) | Medical University of Vienna | 2020-10-05 |
| Safety and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S and a Booster Vaccination With a Licensed Vaccine Against COVID-19 (NCT04569383) | Universitätsklinikum Hamburg-Eppendorf | 2020-10-05 |
| Study of REGN6569 and Cemiplimab in Adult Patients With Advanced Solid Tumor Malignancies (NCT04465487) | Regeneron Pharmaceuticals | 2020-10-05 |
| Safety and Efficacy of AsiDNATM, a DNA Repair Inhibitor, Administered Intravenously in Addition to PARP Inhibitors in Patients With Relapsed Platinum Sensitive Ovarian Cancer Already Treated With PARP Inhibitors Since at Least 6 Months (NCT04826198) | Gustave Roussy, Cancer Campus, Grand Paris | 2020-10-05 |
| This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19 (NCT05046548) | Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products | 2020-10-03 |
| Clinical Study to Evaluate Pharmacokinetics and Safety of PF-06700841 After Single and Multiple Oral Doses as Modified Release Formulations (NCT04580797) | Pfizer | 2020-10-02 |
| Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALL (NCT04524455) | Amgen | 2020-10-02 |
| A Study of Evorpacept (ALX148) With Azacitidine for Higher Risk Myelodysplastic Syndrome (ASPEN-02) (NCT04417517) | ALX Oncology Inc. | 2020-10-02 |
| A Study of Injection HB0017 in Adult Healthy Volunteers (NCT04505033) | Huabo Biopharm Co., Ltd. | 2020-10-02 |
| Rituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL/SLL (NCT03639324) | Virginia Commonwealth University | 2020-10-02 |
| Inflammatory Signal Inhibitors for COVID-19 (MATIS) (NCT04581954) | Imperial College London | 2020-10-02 |
| Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults (NCT04323046) | Sabine Mueller, MD, PhD | 2020-10-02 |
| Study to Evaluate D-1553 in Subjects With Solid Tumors (NCT04585035) | InventisBio Co., Ltd | 2020-10-02 |
| PET Detection of CCR2 in Human Atherosclerosis (NCT04537403) | Washington University School of Medicine | 2020-10-01 |
| The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC (NCT04664829) | National Cancer Centre, Singapore | 2020-10-01 |
| Evaluating Safety & Efficacy Belinostat Combo w Nivo Alone & w Ipi in Patients w Treated Metastatic/Advanced Carcinomas w ARID1A Lof Mutation (NCT04315155) | University of Utah | 2020-10-01 |
| Cell Therapy for CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD7-Specific CAR-T Cells (NCT04572308) | Hebei Senlang Biotechnology Inc., Ltd. | 2020-10-01 |
| PK Study in Patients With Parkinson's Disease With IZD174 (NCT04338997) | Inflazome UK Ltd | 2020-10-01 |
| Maraviroc in Patients With Moderate and Severe COVID-19 (NCT04435522) | Rhode Island Hospital | 2020-10-01 |
| Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers (NCT03924245) | Vanderbilt-Ingram Cancer Center | 2020-10-01 |
| A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer (NCT03327064) | University of Alabama at Birmingham | 2020-10-01 |
| Opioid Sparing Analgesia: Dexmedetomidine Versus Lidocaine for Intracranial Surgeries in Children (NCT04535089) | Zagazig University | 2020-10-01 |
| Fertility Restoration Using Autologous Mesenchymal Stem Cells (NCT04432467) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2020-10-01 |
| Can Ammonium Inhalants Maintain Performance in Sleep Deprived Soldiers? (NCT05868798) | Jan Malecek | 2020-10-01 |
| The Safety and Efficacy of Transarterial Chemoembolization (TACE) + Lenvatinib + Programmed Cell Death Protein 1 (PD-1) Antibody of Advanced Unresectable Hepatocellular Carcinoma (NCT04997850) | Xinrui Zhu，MD | 2020-10-01 |
| TQB3525 for Advanced Bone Sarcomas With PI3KA Mutations or PTEN Loss (NCT04690725) | Peking University People's Hospital | 2020-10-01 |
| Study on the Bioavailability of Three Different Prescription Processes of SHR4640 Tablets in Healthy Volunteers (NCT04586803) | Jiangsu HengRui Medicine Co., Ltd. | 2020-10-01 |
| A Trial of HR18034 in Inguinal Hernia Repair (NCT04551924) | Jiangsu HengRui Medicine Co., Ltd. | 2020-10-01 |
| AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis (NCT05832515) | St. Petersburg State Pavlov Medical University | 2020-10-01 |
| Clinical Assessment of Indirect Restoration Fabricated From Nano Hybrid Composite Blocks Versus Ceramic Blocks in Badly Broken Teeth One Year Follow up (NCT04563624) | Cairo University | 2020-10-01 |
| First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene Mutations (NCT04409145) | Venthera, Inc., a BridgeBio company | 2020-10-01 |
| Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer (NCT04572100) | University of Chicago | 2020-10-01 |
| Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM (NCT04489420) | Celularity Incorporated | 2020-10-01 |
| The Evaluation of Postoperative Antibiotics in Non-Infected Mandible Fractures (NCT04198129) | The University of Texas Health Science Center, Houston | 2020-10-01 |
| Adipose Derived Mesenchymal Cell Treatment in Lungtransplantation (NCT04714801) | Rigshospitalet, Denmark | 2020-10-01 |
| A Study Looking at How Insulin Icodec is Taken up in the Blood When Administered in Different Injection Sites in People With Type 2 Diabetes (NCT04582448) | Novo Nordisk A/S | 2020-10-01 |
| Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache (NCT04353505) | Weill Medical College of Cornell University | 2020-10-01 |
| Alvocidib in Combination With Decitabine and Venetoclax in Patients With Relapsed or Refractory AML or as Frontline Therapy in Unfit Patients With AML (NCT04493099) | M.D. Anderson Cancer Center | 2020-10-01 |
| A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE) (NCT04093349) | Spark Therapeutics, Inc. | 2020-10-01 |
| Topical Naloxone to Diagnose Ocular Pain (NCT04454281) | Seema Capoor | 2020-10-01 |
| Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations (NCT04521686) | Eli Lilly and Company | 2020-10-01 |
| Effect of Vitamin D Therapy in Autism Spectrum Disorder (NCT05595044) | Mansoura University | 2020-10-01 |
| NK Cell Infusion for Patients With Acute Myeloid Leukemia (NCT04221971) | Peking University People's Hospital | 2020-10-01 |
| Ferritin and Iron Burden in SAH sIRB (NCT03754725) | Duke University | 2020-10-01 |
| Scalp Block: Hemodynamic Stability and Patient Comfort In Craniotomy Patients (NCT03177252) | Washington University School of Medicine | 2020-10-01 |
| Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS) (NCT04530604) | Gregory Yanik | 2020-10-01 |
| Effect of 1,25-dihydroxyvitamin D3, Treatment on Insulin Secretion and Muscle Strength in Pre-diabetic Persons (NCT04286529) | Mayo Clinic | 2020-10-01 |
| Stablishment of Prevention and Treatment System for Intestinal Dysfunction (NCT04507945) | Nanjing University School of Medicine | 2020-10-01 |
| Study Evaluating Sodium Selenite in Combination With Abiraterone in Castrate Resistant Prostate Cancer Progressing on Abiraterone (NCT04296578) | Stanford University | 2020-10-01 |
| Clinical Trial to Compare the PK of the Fixed-dose Combinations and Each Component of Gemigliptin/Dapagliflozin 50/10 mg (NCT04544319) | LG Chem | 2020-10-01 |
| Mass Balance Study of [14C]-NT-814 Oral Suspension in Healthy Male Subjects (NCT04654897) | Bayer | 2020-09-30 |
| Study of H3B-6545 in Japanese Women With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer (NCT04568902) | Eisai Co., Ltd. | 2020-09-30 |
| Less Frequent IV Dosing & Tumor Microenvironment (TME) Study of Nemvaleukin Alfa (ALKS 4230) Monotherapy and in Combination With Pembrolizumab (ARTISTRY-3) (NCT04592653) | Mural Oncology, Inc | 2020-09-30 |
| A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19 (NCT04555213) | Noxopharm Limited | 2020-09-30 |
| Study of the Absorption, Metabolism, and Excretion of [14C]-Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) Following a Single Oral Dose in Healthy Male Subjects (NCT04625855) | Spero Therapeutics | 2020-09-30 |
| Safety Evaluation of ART352-L in Subjects Undergoing Posterolateral Spinal Fusion (NCT04378543) | Ankasa Regenerative Therapeutics, Inc. | 2020-09-30 |
| Pharmacodynamic Study of BIIB095 and BIIB074 in Healthy Participants and Participants With Painful Diabetic Polyneuropathy (NCT04106050) | Biogen | 2020-09-30 |
| Evaluation of Effect of Rifampin on the Pharmacokinetics of Vonoprazan in Healthy Participants (NCT04558216) | Phathom Pharmaceuticals, Inc. | 2020-09-30 |
| Stem Cell Therapy for Limbal Stem Cell Deficiency (NCT03957954) | University of California, Los Angeles | 2020-09-30 |
| Effect of Hepatic Impairment on M2951 (BTK Inhibitor) PK (NCT04546789) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2020-09-30 |
| Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD) (NCT04597450) | H. Lundbeck A/S | 2020-09-30 |
| Safety and Efficacy of IBI188 With Azacitidine in Subjects With Newly Diagnosed Higher Risk MDS (NCT04485065) | Innovent Biologics (Suzhou) Co. Ltd. | 2020-09-30 |
| A Study to Evaluate Effects of CC-99677 on the Pharmacokinetics of an Oral Contraceptive in Healthy Female Participants (NCT04718636) | Celgene | 2020-09-30 |
| A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers (NCT05496205) | iN Therapeutics Co., Ltd. | 2020-09-30 |
| A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults and in Children Who Are Respiratory Syncytial Virus (RSV)-Seropositive (NCT04528719) | ModernaTX, Inc. | 2020-09-30 |
| A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes (NCT04569994) | Novo Nordisk A/S | 2020-09-30 |
| Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol) (NCT04373265) | Corcept Therapeutics | 2020-09-30 |
| Study to Learn More About the Effect of a New Drug Called BAY2327949 on the Blood Flow Through Kidneys in Adult Participants With Moderate Chronic Kidney Disease (NCT04552262) | Bayer | 2020-09-30 |
| Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma (NCT04577326) | Memorial Sloan Kettering Cancer Center | 2020-09-30 |
| Safety, Tolerability and Pharmacokinetics (PK) Investigation of GSK3494245 in Healthy Participants (NCT04504435) | GlaxoSmithKline | 2020-09-29 |
| 2018-0674 - IL-7 for T-Cell Recovery Post Haplo and CB Transplant - Phase I/II (NCT03941769) | M.D. Anderson Cancer Center | 2020-09-29 |
| CAR T-cells Against CD30 (HSP-CAR30) for Relapsed/ Refractory Hodgkin and T-cell Lymphoma. (NCT04653649) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2020-09-29 |
| A Study of JNJ-64140284 in Healthy Male Participants (NCT04566926) | Janssen Pharmaceutica N.V., Belgium | 2020-09-29 |
| Detecting Compartment Syndrome Pain in the Presence of Regional Anesthesia in Healthy Volunteers (NCT04113954) | Brigham and Women's Hospital | 2020-09-29 |
| A Phase 1 Study of AZD9833 in Japanese Women With ER Positive, HER2 Negative Advanced Breast Cancer (NCT04541433) | AstraZeneca | 2020-09-29 |
| Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers (NCT04567745) | Mayo Clinic | 2020-09-29 |
| Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma (NCT04577014) | Memorial Sloan Kettering Cancer Center | 2020-09-29 |
| Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy People (NCT04524832) | Novo Nordisk A/S | 2020-09-29 |
| Study of AMG 330 in Combination With Pembrolizumab in Adult With Relapsed or Refractory Acute Myeloid Leukemia (NCT04478695) | Amgen | 2020-09-29 |
| A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults (NCT04552366) | Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China | 2020-09-29 |
| Safety and Pharmacokinetics of VT-1598 (NCT04208321) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-09-29 |
| A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV) (NCT04422912) | Cabaletta Bio | 2020-09-29 |
| REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia (NCT04468971) | Cellenkos, Inc. | 2020-09-29 |
| A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer (NCT04584112) | Hoffmann-La Roche | 2020-09-28 |
| Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors. (NCT04586335) | Haihe Biopharma Co., Ltd. | 2020-09-28 |
| A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects (NCT04516564) | Akesobio Australia Pty Ltd | 2020-09-28 |
| Bioequivalence Study of PF-06651600 Capsules Relative to Tablets and Estimation of Food Effect on Capsules. (NCT04390776) | Pfizer | 2020-09-28 |
| Study of BIIB091 Formulations in Healthy Participants (NCT04564612) | Biogen | 2020-09-28 |
| A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects (NCT05088642) | Jiangsu HengRui Medicine Co., Ltd. | 2020-09-28 |
| Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML (NCT04501120) | Ascentage Pharma Group Inc. | 2020-09-28 |
| Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis (NCT04593251) | Calypso Biotech BV | 2020-09-28 |
| Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer (NCT04420754) | AffyImmune Therapeutics, Inc. | 2020-09-28 |
| PK Study of WD-1603 in Healthy Subjects (NCT04591535) | Hong Kong WD Pharmaceutical Co., Limited | 2020-09-28 |
| Safety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia A (NCT04541628) | Eli Lilly and Company | 2020-09-28 |
| Four-Way Crossover Study to Compare Ferric Maltol Capsules and Oral Suspension in Healthy Volunteers (NCT04626414) | Shield Therapeutics | 2020-09-28 |
| A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants (NCT04316585) | GlaxoSmithKline | 2020-09-28 |
| Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma (Including Ocular Melanoma) (NCT04364230) | Craig L Slingluff, Jr | 2020-09-28 |
| A Study of PRT1419 in Patients With Relapsed/Refractory Hematologic Malignancies (NCT04543305) | Prelude Therapeutics | 2020-09-28 |
| A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation (NCT04494256) | Biogen | 2020-09-28 |